The Incidence and Risk Factors for Allogeneic Blood Transfusions in Pediatric Spine Surgery: National Data.
Justyna Małgorzata FerchoMichał KrakowiakRami YuserTomasz SzmudaPiotr ZielińskiDariusz SzarekGrzegorz MiękisiakPublished in: Healthcare (Basel, Switzerland) (2023)
(1) Background: Pediatric spinal surgery is a blood-intensive procedure. In order to introduce a rational blood management program, identifying the risk factors for transfusions is mandatory. (2) Methods: Data from the national database covering the period from January 2015 to July 2017 were analyzed. The available data included the demographics, characteristics of the surgeries performed, length of stay, and in-house mortality. (3) Results: The total number of patients used for the analysis was 2302. The primary diagnosis was a spinal deformity (88.75%). Most fusions were long, with four levels or more (89.57%). A total of 938 patients received a transfusion; thus, the transfusion rate was 40.75%. The present study identified several risk factors; the most significant was a number of levels fused greater than 4 (RR 5.51; CI95% 3.72-8.15; p < 0.0001), followed by the deformity as the main diagnosis (RR 2.69; CI95% 1.98-3.65; p < 0.0001). These were the two most significant factors increasing the odds of a transfusion. Other factors associated with an increased risk of transfusion were elective surgery, the female sex, and an anterior approach. The mean length of stay in days was 11.42 (SD 9.93); this was greater in the transfused group (14.20 vs. 9.50; p < 0.0001). (4) Conclusions: The rate of transfusions in pediatric spinal surgery remains high. A new patient blood management program is necessary to improve this situation.
Keyphrases
- minimally invasive
- end stage renal disease
- quality improvement
- risk factors
- cardiac surgery
- spinal cord
- electronic health record
- newly diagnosed
- chronic kidney disease
- coronary artery bypass
- emergency department
- peritoneal dialysis
- big data
- type diabetes
- patient reported outcomes
- sickle cell disease
- case report
- coronary artery disease
- patients undergoing
- data analysis
- artificial intelligence
- young adults
- high dose
- adverse drug